ACC 2024: Few Patients With Heart Failure Who Are Eligible Receive Quadruple Medical Therapy
An uptick in prescribing quadruple therapy would have significant effect on 12-month mortality
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.